Some pharmacy schools now use Pharmacy Curriculum Outcomes Assessment scores for academic probation.
Hospital acquisitions and mergers have become common in today's health care environment.
Major patient and professional advocacy organizations discussed factors leading to patient nonadherence to prescription therapy and solutions for overcoming the major barriers.
Therapeutic and subtherapeutic doses of pregabalin were compared to ascertain differences in adherence, healthcare resource use, and cost between the cohorts.
The cost of squamous cell cancer of the head and neck is driven primarily by the end-of-life phase. Treatment costs increased following the approval of cetuximab.
A letter to community oncology pharmacists from Ricky Newtown, CPA, director of Financial Services & Operations, Community Oncology Alliance.
The United States Preventive Services Task Force updates recommends that colorectal cancer screening begin 5 years earlier, at age 45 instead of age 50.
Results from Eisai Inc's online national survey of cancer patients, published in the 2012 Eisai Oncology Digest, highlight financial concerns of cancer treatment and their impact on treatment adherence.
Health care spending in the United States is at the center of a loud, fractured debate mired in deep complexity.
The global launch of a new drug requires careful orchestration of sales and marketing support activities—a challenge that can have a large financial impact.
The pharmacy at KHCC has transformed itself into one of the leading health care providers in the Middle East.
This study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.
There is a number of things that pharmacy students can do to help their communities during the COVID-19 pandemic.
Sephin1 found to protect oligodendrocytes, axons, and myelin, as well as reduce central nervous system inflammation in multiple sclerosis.
Methods Include Bioingestible Sensors, Motivational Interviewing, Packaging and Reminder Technology, and Synchronization
Label change is part an effort to help inform proviers about balancing the serious risks of opioids with their role in pain management.
The involvement of community pharmacists is vital to reduce prescription drug abuse through the use of Electronic Prescription Drug Monitoring Programs.
The 340B program helps rural and urban safety-net health providers care for underserved patients across America every day.
Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Dose optimization strategies offer a potentially valid, clinically based intervention in which payers can realize a direct drug cost savings, and indirect medical cost avoidance.
A review of current treatment recommendations for chronic obstructive pulmonary disease with a focus on currently available medication devices.
A guide to treatment of rheumatoid arthritis, the most common chronic inflammatory joint disease.
Continuous glucose monitoring has revolutionized the way patients with diabetes can monitor their glucose.
Data indicate potential benefits and risks with nutritional supplement use, highlighting the need for pharmacist counseling.
Transitioning infusion therapy patients from hospital outpatient or medical office settings to home care, when appropriate, can result in significant reductions in medical drug spending.